Guardian Pharmacy Services, Inc. (GRDN) stock
GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30160% above fair value
$50.33+0.90 (+1.82%)
Close on Nov 17, 2026Market cap $3.19BP/E –Yield –
Guardian Pharmacy Services operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Guardian Pharmacy Services's operating income for the twelve months ending Jun 30, 2026 was $85.44M. For fiscal 2025 it was $72.70M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.70M | – |
| FY2024 | Dec 31, 2024 | -$62.92M | -253.7% |
| FY2023 | Dec 31, 2023 | $40.95M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $20.64M | +64.1% |
| Q1 FY2026 | Mar 31, 2026 | $17.68M | +35.9% |
| Q4 FY2025 | Dec 31, 2025 | $30.76M | +83.6% |
| Q3 FY2025 | Sep 30, 2025 | $16.35M | – |
| Q2 FY2025 | Jun 30, 2025 | $12.58M | -26.0% |
| Q1 FY2025 | Mar 31, 2025 | $13.01M | +63.9% |
| Q4 FY2024 | Dec 31, 2024 | $16.76M | +7.9% |
| Q3 FY2024 | Sep 30, 2024 | -$104.61M | – |
| Q2 FY2024 | Jun 30, 2024 | $17.01M | – |
| Q1 FY2024 | Mar 31, 2024 | $7.93M | – |
| Q4 FY2023 | Dec 31, 2023 | $15.52M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.33M | – |
See a number that looks wrong?